ProAssurance Net Income Halves Amid Premium Decline, Investment Gains Up

TL;DR

**PRA's net income got absolutely crushed, but a jump in investment income and AOCI growth might signal a turnaround in the long run.**

AI Summary

PROASSURANCE CORP reported a significant decline in net income for the nine months ended September 30, 2025, falling to $17.545 million from $36.575 million in the prior year, a decrease of 52.03%. Net premiums earned also decreased by 3.45% to $702.086 million from $727.176 million. Despite these declines, net investment income saw an increase of 8.00% to $116.326 million from $107.727 million. The company's total assets slightly decreased to $5.552 billion from $5.574 billion, while total shareholders' equity increased by 8.53% to $1.304 billion from $1.202 billion, primarily driven by an $81.550 million increase in accumulated other comprehensive income. The reserve for losses and loss adjustment expenses decreased by 4.26% to $3.119 billion from $3.258 billion. Operating expenses increased to $146.772 million from $138.544 million, and net losses and loss adjustment expenses decreased to $536.097 million from $557.025 million.

Why It Matters

This 10-Q reveals a challenging period for ProAssurance, with net income dropping over 50% and premiums earned declining. For investors, this signals potential headwinds in core underwriting profitability and could impact future dividend stability or share price appreciation. Employees might face pressure if cost-cutting measures are implemented to offset declining revenues. Customers could see changes in policy offerings or pricing as the company adjusts to market conditions and competitive pressures, especially in the Medical Professional Liability (MPL) sector. The broader market, particularly the specialty insurance segment, will watch how ProAssurance navigates these challenges, as its performance can reflect trends in medical and social inflation and the competitive landscape.

Risk Assessment

Risk Level: medium — The company experienced a significant 52.03% drop in net income, from $36.575 million to $17.545 million, and a 3.45% decrease in net premiums earned, indicating core business challenges. However, the increase in accumulated other comprehensive income (loss) by $81.550 million and a reduction in the reserve for losses and loss adjustment expenses by $138.759 million suggest some financial stabilization and potential for future improvement.

Analyst Insight

Investors should closely monitor PROASSURANCE CORP's upcoming earnings calls for detailed explanations on the net income decline and strategies to reverse the trend in net premiums earned. While the increase in AOCI is positive, the core underwriting performance needs to improve. Consider holding existing positions but deferring new investments until a clearer path to sustained profitability in core operations is demonstrated.

Financial Highlights

debt To Equity

0.32

revenue

$702.086M

operating Margin

N/A

total Assets

$5.552B

total Debt

$421.523M

net Income

$17.545M

eps

$0.34

gross Margin

N/A

cash Position

$54.457M

revenue Growth

-3.45%

Revenue Breakdown

Key Numbers

• $17.545M — Net income (Decreased by 52.03% from $36.575 million year-over-year for the nine months ended September 30, 2025.)
• $702.086M — Net premiums earned (Decreased by 3.45% from $727.176 million year-over-year for the nine months ended September 30, 2025.)
• $116.326M — Net investment income (Increased by 8.00% from $107.727 million year-over-year for the nine months ended September 30, 2025.)
• $5.552B — Total Assets (Slightly decreased from $5.574 billion as of December 31, 2024.)
• $1.304B — Total Shareholders' Equity (Increased by 8.53% from $1.202 billion as of December 31, 2024.)
• $90.841M — Accumulated other comprehensive income (loss) (Improved from a loss of $172.391 million as of December 31, 2024.)
• $3.119B — Reserve for losses and loss adjustment expenses (Decreased by 4.26% from $3.258 billion as of December 31, 2024.)
• $0.34 — Diluted EPS (Decreased from $0.71 year-over-year for the nine months ended September 30, 2025.)
• 51,413,643 — Common shares outstanding (As of October 30, 2025.)
• $421.523M — Debt less unamortized debt issuance costs (Slightly decreased from $424.873 million as of December 31, 2024.)

Key Players & Entities

• PROASSURANCE CORP (company) — registrant
• The Doctors Company (company) — proposed merger partner
• New York Stock Exchange (regulator) — exchange where PRA is registered
• SEC (regulator) — Securities and Exchange Commission
• FASB (regulator) — Financial Accounting Standards Board
• PCAOB (regulator) — Public Company Accounting Oversight Board
• Delaware (regulator) — state of incorporation
• Lloyd's of London (company) — insurance market
• NORCAL Insurance Company (company) — formerly NORCAL Mutual Insurance Company
• Preferred Physicians Medical Risk Retention Group (company) — a Mutual Insurance Company

FAQ

Risk Factors

• Reserve Adequacy [high — financial]: The reserve for losses and loss adjustment expenses decreased by 4.26% to $3.119 billion from $3.258 billion. Changes in estimates for losses can significantly impact financial results.
• Investment Performance [medium — market]: Total investments increased to $4.438 billion from $4.367 billion. While net investment income grew 8.00% to $116.326 million, the value of fixed maturity investments available-for-sale decreased to $3.679 billion from $3.582 billion.
• Operating Expense Management [medium — operational]: Operating expenses increased to $146.772 million from $138.544 million. Managing these costs is crucial for profitability, especially with declining net premiums earned.
• Net Income Decline [high — financial]: Net income for the nine months ended September 30, 2025, fell to $17.545 million from $36.575 million, a 52.03% decrease. This significant drop warrants investigation into underlying causes.
• Regulatory Compliance [medium — regulatory]: As a regulated insurance entity, ProAssurance is subject to various state and federal regulations. Non-compliance can lead to fines, sanctions, and reputational damage.
• Deferred Tax Asset Fluctuation [low — financial]: Deferred tax assets, net, decreased to $132.952 million from $163.928 million. Changes in tax assets can reflect shifts in profitability or tax planning strategies.

Industry Context

The insurance industry, particularly in specialty lines like those ProAssurance operates in, is characterized by intense competition, evolving regulatory landscapes, and sensitivity to economic conditions. Insurers face ongoing challenges in managing underwriting profitability, investment returns, and operational efficiency. Trends include a focus on digital transformation, data analytics for risk assessment, and adapting to changing customer expectations.

Regulatory Implications

ProAssurance operates under stringent insurance regulations that vary by jurisdiction. Compliance with capital requirements, solvency standards, and consumer protection laws is paramount. Changes in accounting standards or regulatory pronouncements related to reserves, investments, or capital adequacy could materially impact financial reporting and operations.

What Investors Should Do

1. Investigate the drivers behind the significant 52.03% decline in net income.
2. Monitor the adequacy and development of the loss reserves.
3. Analyze the impact of increased operating expenses on margins.
4. Assess the sustainability of investment income growth.

Glossary

Net premiums earned

The portion of insurance premiums that corresponds to the coverage provided during a specific period. (Indicates the revenue generated from insurance policies in force.)

Reserve for losses and loss adjustment expenses

An estimate of the amount the company expects to pay for claims that have occurred but have not yet been settled, plus the costs associated with settling those claims. (A critical liability for an insurance company, reflecting future obligations.)

Accumulated other comprehensive income (loss)

A component of shareholders' equity that includes unrealized gains and losses on investments, foreign currency translation adjustments, and other items not included in net income. (Can significantly impact total shareholders' equity, as seen with the $81.550 million increase driven by this item.)

Deferred policy acquisition costs

Costs incurred in acquiring new insurance policies, such as commissions and underwriting expenses, that are capitalized and amortized over the life of the policy. (Represents costs related to future revenue streams.)

Operating lease ROU assets

Assets representing the right to use an underlying asset for the lease term, arising from operating leases. (Reflects the company's obligations and usage of leased assets.)

Year-Over-Year Comparison

For the nine months ended September 30, 2025, ProAssurance Corp experienced a significant 52.03% decrease in net income compared to the prior year, falling to $17.545 million. This was accompanied by a 3.45% decline in net premiums earned, indicating a contraction in core insurance revenue. However, net investment income showed resilience, growing by 8.00%. Total assets saw a slight decrease, while shareholders' equity increased by 8.53%, largely due to a substantial improvement in accumulated other comprehensive income.

Key Financial Figures

• $0.01 — ich registered Common Stock, par value $0.01 per share PRA New York Stock Exchange
• $250 million — olving Credit Agreement ProAssurance's $250 million revolving credit agreement ROE Return
• $125 million — H.R.1 of 2017 Term Loan ProAssurance's $125 million delayed draw term loan U.K. United Ki

Filing Documents

• pra-20250930.htm (10-Q) — 4193KB
• pra-20250930xex311.htm (EX-31.1) — 7KB
• pra-20250930xex312.htm (EX-31.2) — 7KB
• pra-20250930xex321.htm (EX-32.1) — 4KB
• pra-20250930xex322.htm (EX-32.2) — 4KB
• pra-20250930_g1.jpg (GRAPHIC) — 42KB
• pra-20250930_g2.jpg (GRAPHIC) — 31KB
• pra-20250930_g3.jpg (GRAPHIC) — 111KB
• 0001127703-25-000013.txt ( ) — 15915KB
• pra-20250930.xsd (EX-101.SCH) — 56KB
• pra-20250930_cal.xml (EX-101.CAL) — 99KB
• pra-20250930_def.xml (EX-101.DEF) — 345KB
• pra-20250930_lab.xml (EX-101.LAB) — 787KB
• pra-20250930_pre.xml (EX-101.PRE) — 568KB
• pra-20250930_htm.xml (XML) — 3411KB

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION ITEM 1.

FINANCIAL STATEMENTS

FINANCIAL STATEMENTS CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - SEPTEMBER 30, 2025 AND DECEMBER 31, 2024 7 CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN CAPITAL (UNAUDITED) - THREE AND N INE MONTHS ENDED SEPTEMBER 30, 2025 AND 2024 8 CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (UNAUDITED) - THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025 AND 2024 9 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - N INE MONTHS ENDED SEPTEMBER 30, 2025 AND 2024 10 NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) 12 BASIS OF PRESENTATION 12 FAIR VALUE MEASUREMENT 14 INVESTMENTS 21 INCOME TAXES 28 RESERVE FOR LOSSES AND LOSS ADJUSTMENT EXPENSES 28 COMMITMENTS AND CONTINGENCIES 30 DEBT 30 DERIVATIVES 31 SHAREHOLDERS' EQUITY 32 VARIABLE INTEREST ENTITIES 33 EARNINGS (LOSS) PER SHARE 34 SEGMENT INFORMATION 34 ITEM 2.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 39 ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 78 ITEM 4.

CONTROLS AND PROCEDURES

CONTROLS AND PROCEDURES 81

OTHER INFORMATION

PART II. OTHER INFORMATION ITEM 1.

LEGAL PROCEEDINGS

LEGAL PROCEEDINGS 81 ITEM 1A.

RISK FACTORS

RISK FACTORS 81 ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 82 ITEM 5. OTHER INFORMATION 82 ITEM 6. EXHIBITS 83 SIGNATURE 83 6 Table of Contents ProAssurance Corporation and Subsidiaries Condensed Consolidated Balance Sheets (Unaudited) (In thousands, except share data) September 30, 2025 December 31, 2024 Assets Investments Fixed maturities, available-for-sale, at fair value (amortized cost, $ 3,798,274 and $ 3,803,835 , respectively; allowance for expected credit losses, $ 4,031 and $ 3,399 , respectively) $ 3,679,182 $ 3,582,207 Fixed maturities, trading, at fair value (cost, $ 12,304 and $ 52,493 , respectively) 12,390 53,157 Equity investments, at fair value (cost, $ 120,665 and $ 145,411 , respectively) 110,198 130,158 Short-term investments 291,345 254,922 Business owned life insurance 82,346 80,179 Investment in unconsolidated subsidiaries 253,085 259,538 Other investments (at fair value, $ 2,137 and $ 2,077 , respectively, otherwise at cost or amortized cost) 9,309 7,266 Total Investments 4,437,855 4,367,427 Cash and cash equivalents 54,457 54,881 Premiums receivable, net (allowance for expected credit losses, $ 7,957 and $ 8,141 , respectively) 255,677 228,900 Receivable from reinsurers on paid losses and loss adjustment expenses 17,787 18,226 Receivable from reinsurers on unpaid losses and loss adjustment expenses 363,663 409,069 Prepaid reinsurance premiums 39,164 30,623 Deferred policy acquisition costs 59,895 59,026 Deferred tax asset, net 132,952 163,928 Real estate, net 14,873 29,581 Operating lease ROU assets 14,491 16,514 Intangible assets, net 49,822 54,208 Goodwill 5,500 5,500 Other assets 106,037 136,390 Total Assets $ 5,552,173 $ 5,574,273 Liabilities and Shareholders' Equity Liabilities Policy liabilities and accruals Reserve for losses and loss adjustment expenses $ 3,118,937 $ 3,257,696 Unearned premiums 458,376 418,756 Reinsurance premiums payable 26,091 27

View Full Filing

View this 10-Q filing on SEC EDGAR